Minerva Neurosciences, Inc. — Cash Flow Charts
46 quarters of history · ending 2024-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-5180.7% -$6M
$-6M
Free Cash Flow↓-5180.7% -$6M
$-6M
Investing Cash Flow
$0
Financing Cash Flow↓-100.0% -$20M
$0
Capex
$19K
Stock Buybacks
$0
Stock-Based Comp↓-59.1% -$361K
$250K
Debt Repaid
$0
D&A↓-0.1% -$1
$1K
SBC Allocated Expense↓-59.1% -$361K
$250K
SBC Unrecognized Cost↑+119.4% +$4M
$8M